These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32123046)
21. Fatigue in multiple sclerosis: The contribution of occult white matter damage. Bisecco A; Caiazzo G; d'Ambrosio A; Sacco R; Bonavita S; Docimo R; Cirillo M; Pagani E; Filippi M; Esposito F; Tedeschi G; Gallo A Mult Scler; 2016 Nov; 22(13):1676-1684. PubMed ID: 26846989 [TBL] [Abstract][Full Text] [Related]
22. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835 [TBL] [Abstract][Full Text] [Related]
23. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus. Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559 [TBL] [Abstract][Full Text] [Related]
24. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study. Kolasa M; Hakulinen U; Brander A; Hagman S; Dastidar P; Elovaara I; Sumelahti ML Brain Behav; 2019 Jan; 9(1):e01194. PubMed ID: 30588771 [TBL] [Abstract][Full Text] [Related]
25. Diffusion basis spectrum imaging provides insights into MS pathology. Sun P; George A; Perantie DC; Trinkaus K; Ye Z; Naismith RT; Song SK; Cross AH Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31871296 [TBL] [Abstract][Full Text] [Related]
26. Microglial activation, white matter tract damage, and disability in MS. Rissanen E; Tuisku J; Vahlberg T; Sucksdorff M; Paavilainen T; Parkkola R; Rokka J; Gerhard A; Hinz R; Talbot PS; Rinne JO; Airas L Neurol Neuroimmunol Neuroinflamm; 2018 May; 5(3):e443. PubMed ID: 29520366 [TBL] [Abstract][Full Text] [Related]
27. Natalizumab treatment reduces microglial activation in the white matter of the MS brain. Sucksdorff M; Tuisku J; Matilainen M; Vuorimaa A; Smith S; Keitilä J; Rokka J; Parkkola R; Nylund M; Rinne J; Rissanen E; Airas L Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e574. PubMed ID: 31355310 [TBL] [Abstract][Full Text] [Related]
28. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Griffin CM; Chard DT; Ciccarelli O; Kapoor B; Barker GJ; Thompson AI; Miller DH Mult Scler; 2001 Oct; 7(5):290-7. PubMed ID: 11724444 [TBL] [Abstract][Full Text] [Related]
29. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients. Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600 [TBL] [Abstract][Full Text] [Related]
30. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis. Preziosa P; Pagani E; Meani A; Marchesi O; Conti L; Falini A; Rocca MA; Filippi M J Neurol; 2023 Feb; 270(2):810-823. PubMed ID: 36201016 [TBL] [Abstract][Full Text] [Related]
31. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study. de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571 [TBL] [Abstract][Full Text] [Related]
32. Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study. Bernitsas E; Kopinsky H; Lichtman-Mikol S; Razmjou S; Santiago-Martinez C; Yarraguntla K; Bao F J Neuroimaging; 2021 Mar; 31(2):379-387. PubMed ID: 33368776 [TBL] [Abstract][Full Text] [Related]
33. Datta G; Colasanti A; Kalk N; Owen D; Scott G; Rabiner EA; Gunn RN; Lingford-Hughes A; Malik O; Ciccarelli O; Nicholas R; Nei L; Battaglini M; De Stefano N; Matthews PM J Nucl Med; 2017 Sep; 58(9):1477-1482. PubMed ID: 28302760 [TBL] [Abstract][Full Text] [Related]
34. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis. Lommers E; Simon J; Reuter G; Delrue G; Dive D; Degueldre C; Balteau E; Phillips C; Maquet P Neuroimage Clin; 2019; 23():101879. PubMed ID: 31176293 [TBL] [Abstract][Full Text] [Related]
35. Diffusion Tensor Imaging Revealed Microstructural Changes in Normal-Appearing White Matter Regions in Relapsing-Remitting Multiple Sclerosis. Bao J; Tu H; Li Y; Sun J; Hu Z; Zhang F; Li J Front Neurosci; 2022; 16():837452. PubMed ID: 35310094 [TBL] [Abstract][Full Text] [Related]
36. White matter microstructural alterations in clinically isolated syndrome and multiple sclerosis. Huang J; Liu Y; Zhao T; Shu N; Duan Y; Ren Z; Sun Z; Liu Z; Chen H; Dong H; Li K J Clin Neurosci; 2018 Jul; 53():27-33. PubMed ID: 29754967 [TBL] [Abstract][Full Text] [Related]
37. Microstructural changes of normal-appearing white matter in Vascular Parkinsonism. Salsone M; Caligiuri ME; Vescio V; Arabia G; Cherubini A; Nicoletti G; Morelli M; Quattrone A; Vescio B; Nisticò R; Novellino F; Cascini GL; Sabatini U; Montilla M; Rektor I; Quattrone A Parkinsonism Relat Disord; 2019 Jun; 63():60-65. PubMed ID: 30852150 [TBL] [Abstract][Full Text] [Related]
38. The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS. Pardini M; Petracca M; Harel A; Fleysher L; Oesingmann N; Bommarito G; Fabian M; Chard D; Lublin F; Inglese M Neuroimage Clin; 2017; 16():111-115. PubMed ID: 28794971 [TBL] [Abstract][Full Text] [Related]
39. Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate. Alshehri A; Al-Iedani O; Koussis N; Khormi I; Lea R; Lechner-Scott J; Ramadan S Neuroradiol J; 2023 Aug; 36(4):388-396. PubMed ID: 36395524 [TBL] [Abstract][Full Text] [Related]
40. Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics. Asaf A; Evan S; Anat A Neuroimage Clin; 2015; 8():261-6. PubMed ID: 26106550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]